Acta Pharmacologica Sinica

Acta Pharmacologica Sinica

药理学报

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Acta Pharmacologica Sinica》是由Nature Publishing Group出版社于1980年创办的英文国际期刊(ISSN: 1671-4083,E-ISSN: 1745-7254),该期刊长期致力于药学领域的创新研究,主要研究方向为化学综合-医学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.0925...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比91.03%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在156篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Acta Pharmacologica Sinica审稿周期约为 约2月 。该刊近年未被列入国际预警名单,年发文量约156篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 156 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
PHARMACOLOGY & PHARMACY 药学 CHEMISTRY, MULTIDISCIPLINARY 化学:综合
1区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
1区 1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q1 47 / 230

79.8%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 15 / 354

95.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q1 34 / 231

85.5%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 28 / 354

92.23%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15.1 SJR:1.882 SNIP:1.38
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 8 / 272

97%

大类:Medicine 小类:Pharmacology Q1 15 / 313

95%

期刊发文

  • Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity

    Author: Zhong, Xian-Chun; Liu, Ya-Meng; Gao, Xiao-Xia; Krausz, Kristopher W.; Niu, Bing; Gonzalez, Frank J.; Xie, Cen

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 145-156. DOI: 10.1038/s41401-022-00921-7

  • Hepatocyte-derived MANF mitigates ethanol-induced liver steatosis in mice via enhancing ASS1 activity and activating AMPK pathway

    Author: Xu, Han-Yang; Jiao, Yan-Hong; Li, Shi-Yu; Zhu, Xu; Wang, Sheng; Zhang, Yu-Yang; Wei, Yi-Jun; Shen, Yu-Jun; Wang, Wei; Shen, Yu-Xian; Shao, Jun-Tang

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 157-168. DOI: 10.1038/s41401-022-00920-8

  • Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation

    Author: Huang, Jian-rong; Zhang, Ming-hua; Chen, Ying-jie; Sun, Yu-ling; Gao, Zhi-min; Li, Zhuo-jia; Zhang, Gui-ping; Qin, Yuan; Dai, Xiao-yan; Yu, Xi-yong; Wu, Xiao-qian

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 2, pp. 321-331. DOI: 10.1038/s41401-022-00919-1

  • Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling

    Author: Zhao, Zhen-Xiong; Zhang, Yan-Qiu; Sun, Hui; Chen, Zi-Qi; Chang, Jin-Jia; Wang, Xin; Wang, Xu; Tan, Cong; Ni, Shu-Juan; Weng, Wei-Wei; Zhang, Meng; Wang, Lei; Huang, Dan; Feng, Yun; Sheng, Wei-Qi; Xu, Mi-Die

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 178-188. DOI: 10.1038/s41401-022-00927-1

  • Pharmacokinetics, mass balance, and metabolism of [C-14]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension

    Author: He, Yi-fei; Liu, Yin; Yu, Jing-hua; Cheng, Huan; Odilov, Abdullajon; Yang, Fei-pu; Tian, Guang-hui; Yao, Xiu-mei; Duan, Hua-qing; Yu, Cheng-yin; Yu, Chen; Liu, Yan-mei; Liu, Gang-yi; Shen, Jing-shan; Wang, Zhen; Diao, Xing-xing

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 221-233. DOI: 10.1038/s41401-022-00922-6

  • Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation

    Author: Wang, Min-xiu; Luo, Wu; Ye, Lin; Jin, Lei-ming; Yang, Bin; Zhang, Qian-hui; Qian, Jian-chang; Wang, Yi; Zhang, Yi; Liang, Guang

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 120-132. DOI: 10.1038/s41401-022-00926-2

  • Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer

    Author: Zhao, Zi-tong; Wang, Jue; Fang, Lei; Qian, Xin-di; Cai, Ying; Cao, Hai-qiang; Wang, Guan-ru; He, Mei-lin; Jiang, Yan-yan; Wang, Dang-ge; Li, Ya-ping

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 244-254. DOI: 10.1038/s41401-022-00930-6

  • Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease

    Author: Wu, Jing; Lou, Yun-ge; Yang, Xu-le; Wang, Rui; Zhang, Ran; Aa, Ji-ye; Wang, Guang-ji; Xie, Yuan

    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 133-144. DOI: 10.1038/s41401-022-00924-4